EA201790388A1 - Способ получения n-[4-(1-циклобутилпиперидин-4-илокси)фенил]-2-(морфолин-4-ил)ацетамиддигидрохлорида в большом масштабе - Google Patents

Способ получения n-[4-(1-циклобутилпиперидин-4-илокси)фенил]-2-(морфолин-4-ил)ацетамиддигидрохлорида в большом масштабе

Info

Publication number
EA201790388A1
EA201790388A1 EA201790388A EA201790388A EA201790388A1 EA 201790388 A1 EA201790388 A1 EA 201790388A1 EA 201790388 A EA201790388 A EA 201790388A EA 201790388 A EA201790388 A EA 201790388A EA 201790388 A1 EA201790388 A1 EA 201790388A1
Authority
EA
Eurasian Patent Office
Prior art keywords
phenyl
cyclobutylipiperidin
acetamiddyhydrochloride
morfolin
iloxy
Prior art date
Application number
EA201790388A
Other languages
English (en)
Other versions
EA032823B1 (ru
Inventor
Рамакришна Нироджи
Анил Карбхари Схинде
Рамасастри Камбхампати
Венкатесварлу Джасти
Original Assignee
Сувен Лайф Сайенсиз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сувен Лайф Сайенсиз Лимитед filed Critical Сувен Лайф Сайенсиз Лимитед
Publication of EA201790388A1 publication Critical patent/EA201790388A1/ru
Publication of EA032823B1 publication Critical patent/EA032823B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Настоящее изобретение относится к способу получения N-[4-(1-циклобутилпиперидин-4-илокси)фенил]-2-(морфолин-4-ил)ацетамиддигидрохлорида формулы (I) в большом масштабе.
EA201790388A 2014-08-16 2014-10-20 Способ получения n-[4-(1-циклобутилпиперидин-4-илокси)фенил]-2-(морфолин-4-ил)ацетамиддигидрохлорида в большом масштабе EA032823B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN4010CH2014 2014-08-16
PCT/IN2014/000666 WO2016027275A1 (en) 2014-08-16 2014-10-20 Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride

Publications (2)

Publication Number Publication Date
EA201790388A1 true EA201790388A1 (ru) 2017-06-30
EA032823B1 EA032823B1 (ru) 2019-07-31

Family

ID=52339255

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201790388A EA032823B1 (ru) 2014-08-16 2014-10-20 Способ получения n-[4-(1-циклобутилпиперидин-4-илокси)фенил]-2-(морфолин-4-ил)ацетамиддигидрохлорида в большом масштабе

Country Status (28)

Country Link
US (1) US9802896B2 (ru)
EP (1) EP3180334B1 (ru)
JP (1) JP6385580B2 (ru)
KR (1) KR101860487B1 (ru)
CN (1) CN106573925B (ru)
AP (1) AP2017009753A0 (ru)
AU (1) AU2014403999B2 (ru)
BR (1) BR112017002922B1 (ru)
CA (1) CA2957494C (ru)
CY (1) CY1121253T1 (ru)
DK (1) DK3180334T3 (ru)
EA (1) EA032823B1 (ru)
ES (1) ES2693378T3 (ru)
HK (1) HK1231472A1 (ru)
HR (1) HRP20181801T1 (ru)
HU (1) HUE041465T2 (ru)
IL (1) IL250412B (ru)
LT (1) LT3180334T (ru)
MX (1) MX364931B (ru)
NZ (1) NZ728915A (ru)
PL (1) PL3180334T3 (ru)
PT (1) PT3180334T (ru)
RS (1) RS57927B1 (ru)
SG (1) SG11201701104SA (ru)
SI (1) SI3180334T1 (ru)
TR (1) TR201816175T4 (ru)
WO (1) WO2016027275A1 (ru)
ZA (1) ZA201700936B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202092979A1 (ru) 2018-05-31 2021-03-12 Сувен Лайф Сайенсиз Лимитед Способ лечения обратным агонистом гистаминового рецептора 3 типа

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904738D0 (sv) * 1999-12-22 1999-12-22 Astra Pharma Prod Novel compounds
JP5663605B2 (ja) * 2011-02-04 2015-02-04 イハラケミカル工業株式会社 アミノフェニルピリミジニルアルコール誘導体の製造方法及びその合成中間体
EA023260B1 (ru) 2011-02-23 2016-05-31 Сувен Лайф Сайенсиз Лимитед Новые соединения в качестве лигандов гистаминовых h-рецепторов

Also Published As

Publication number Publication date
SG11201701104SA (en) 2017-03-30
HRP20181801T1 (hr) 2018-12-28
US20170260135A1 (en) 2017-09-14
AU2014403999A1 (en) 2017-02-23
TR201816175T4 (tr) 2018-11-21
CN106573925B (zh) 2020-04-10
IL250412A0 (en) 2017-03-30
KR20170036044A (ko) 2017-03-31
EA032823B1 (ru) 2019-07-31
CA2957494A1 (en) 2016-02-25
MX364931B (es) 2019-05-14
AU2014403999B2 (en) 2017-12-14
WO2016027275A1 (en) 2016-02-25
DK3180334T3 (en) 2018-11-26
HUE041465T2 (hu) 2019-05-28
AP2017009753A0 (en) 2017-02-28
CN106573925A (zh) 2017-04-19
JP2017525761A (ja) 2017-09-07
SI3180334T1 (sl) 2019-01-31
PL3180334T3 (pl) 2019-03-29
HK1231472A1 (zh) 2017-12-22
RS57927B1 (sr) 2019-01-31
KR101860487B1 (ko) 2018-05-23
CA2957494C (en) 2018-08-28
ZA201700936B (en) 2019-07-31
NZ728915A (en) 2018-01-26
PT3180334T (pt) 2018-11-16
MX2017002043A (es) 2017-05-04
JP6385580B2 (ja) 2018-09-05
BR112017002922A2 (pt) 2017-12-05
EP3180334B1 (en) 2018-09-26
LT3180334T (lt) 2018-11-12
EP3180334A1 (en) 2017-06-21
ES2693378T3 (es) 2018-12-11
IL250412B (en) 2019-11-28
CY1121253T1 (el) 2020-05-29
US9802896B2 (en) 2017-10-31
BR112017002922B1 (pt) 2023-01-03

Similar Documents

Publication Publication Date Title
EA201792535A1 (ru) Гетероциклические амиды в качестве ингибиторов киназ
TR201906366T4 (tr) Polisiklik-karbamoilpiridon bileşiklerinin sentezi.
EA201691799A1 (ru) Бициклические соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
CU20150129A7 (es) Derivados de 3-acetilamino-1 (fenil-heteroaril-aminocarbonil o fenil-heteroaril-carbonilamino) benceno para el tratamiento de desordenes hiperproliferativos
EA201790983A1 (ru) Синтез копанлисиба и его дигидрохлорида
EA201591634A1 (ru) Дигидропиридопиримидиновые соединения
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
CL2015002309A1 (es) Proceso de fabricacion de vortioxetina.
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
BR112016021910A2 (pt) Processo de preparação de 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h-imidazo[4,5-b]piridin-2-il)piridin-2-amina
MA50917A (fr) Nouvelles formes cristallines du sel monosodique du foramsulfuron
EA201692246A1 (ru) Способ получения 2,6-диметилбензохинона
EA201790388A1 (ru) Способ получения n-[4-(1-циклобутилпиперидин-4-илокси)фенил]-2-(морфолин-4-ил)ацетамиддигидрохлорида в большом масштабе
CY1124594T1 (el) Καινοφανης πολυμορφικη μορφη της υδροχλωρικης ν-[2-(6-φθορο-lη-ινδολ-3-υλ)αιθυλ]-3-(2,2,3,3-τετραφθοροπροποξυ)βενζυλαμινης για την αγωγη της αλτσχαϊμεp
DK3247699T3 (da) Proces til produktion of 2-[4-(cyclopropancarbonyl)phenyl]-2-methyl-propannitril
MX2017012960A (es) Metodo para producir acilsulfamoilbenzamidas.
EA201790238A1 (ru) Кристаллические ингибиторы bace
EA201892406A1 (ru) Способ получения гербицидных пиридинилимидазолоновых соединений
TH1701000768A (th) กระบวนการสำหรับการผลิตขนาดใหญ่ของ n-[4-(1-ไซโคลบิวทิลพิเพอริดิน-4- อิลอกซี)เฟนิล]-2-(มอร์โฟลิน-4-อิล)อะซีตาไมด์ไดไฮโดรคลอไรด์
TH169412B (th) กระบวนการสำหรับการผลิตขนาดใหญ่ของ n-[4-(1-ไซโคลบิวทิลพิเพอริดิน-4- อิลอกซี)เฟนิล]-2-(มอร์โฟลิน-4-อิล)อะซีตาไมด์ไดไฮโดรคลอไรด์
EA201892405A1 (ru) Синтез индазолов
UA105576U (uk) 1-[3-нітрозо-3-(2-хлороетил)уреїдо]-поліфлуороалкілфосфонати
UA114161C2 (xx) Сіль 3-карбокси-4-(r)-фенілпіролідин-2-ону та її застосування
TH1601002555A (th) เบนซาไมด์ซึ่งถูกแทนที่สำหรับการปฏิบัติต่อสัตว์ขาปล้อง
TH1601002537A (th) กระบวนการสำหรับการสังเคราะห์สารยับยั้งอินโดลเอมีน 2,3-ไดออกซีจีเนสชนิดหนึ่ง